Skip to main content
. 2012 Mar;9(1):57–62. doi: 10.3969/j.issn.2095-3941.2012.01.011

Table 1. Patients’ characteristics.

With liver metastasis Without liver metastasis Transfer rate (%) Z P
Primary tumor (UICC stage)
    T0 0 2 0.00 -0.59 0.555
    T1 17 102 14.29
    T2 52 211 19.77
    T3 3 35 7.89
    T4 3 4 42.86
Lymph node metastasis (UICC stage)
    N0 12 110 9.84 -3.883 <0.001
    N1 20 112 15.15
    N2 12 65 15.58
    N3 31 67 31.63
TNM staging (UICC stage)
    0 0 2 0.00 -2.961 0.003
    I 6 43 12.24
    II 24 168 12.50
    III 45 141 24.19
Immunohistochemical testing
    ER+ 39 171 18.57 -0.347 0.729
    ER- 45 178 20.18
    PR+ 32 161 16.58 -0.466 0.641
    PR- 44 188 18.97
    HER-2/neu (cerbB-2)+ 38 109 25.85 -3.024 0.002
    HER-2/neu (cerbB-2)- 34 233 12.73